GeneDx Stock (NASDAQ:WGS)
Previous Close
$85.10
52W Range
$55.17 - $170.87
50D Avg
$99.60
200D Avg
$111.01
Market Cap
$2.25B
Avg Vol (3M)
$701.77K
Beta
2.15
Div Yield
-
WGS Company Profile
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
WGS Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 22 |
|---|---|---|---|
| Diagnostic Test | $416.67M | $302.16M | $227.33M |
| Diagnostic Test, Institutional Customers | $70.07M | $65.11M | - |
| Diagnostic Test, Self Pay | $1.36M | $2.34M | - |
| Diagnostic Test, Third Party Insurance | $345.24M | $234.70M | - |
| Product and Service, Other | $10.87M | $3.29M | $7.36M |
Fiscal year ends in Dec 25 | Currency in USD